Because p53 mutations occur most commonly in the ER-negative disease and women from a low SES background were found to be more likely to develop an ER-negative disease than those from a high SES background, we performed an additional analysis of the association between HI and the p53 mutation frequency after stratification of the patients by tumor ER status. The gene discussed is TP53; the disease is neoplasm.